Log in

OTCMKTS:INBP - Integrated BioPharma Stock Price, Forecast & News

+0.05 (+16.13 %)
(As of 02/16/2020 04:00 PM ET)
Today's Range
Now: $0.36
50-Day Range
MA: $0.24
52-Week Range
Now: $0.36
Volume76,800 shs
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio6.00
Dividend YieldN/A
Integrated Biopharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through three segments: Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Branded Proprietary Products segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Naturally Noni, Peaceful Sleep, Green Envy, FiberCal, and Wheatgrass brands, as well as other branded proprietary nutraceutical products. The Other Nutraceutical Businesses segment sells private label vitamin and nutritional supplement products, and healthful nutritional products through the Internet; and distributes fine natural botanicals, including multi minerals, as well as raw materials. This segment also provides warehousing and fulfilment services. The company was formerly known as Integrated Health Technologies, Inc. Integrated Biopharma, Inc. was founded in 1979 and is based in Hillside, New Jersey.

Industry, Sector and Symbol

Industry N/A
Current SymbolOTCMKTS:INBP



Sales & Book Value

Annual SalesN/A



Next Earnings Date2/19/2020 (Estimated)
OptionableNot Optionable

Receive INBP News and Ratings via Email

Sign-up to receive the latest news and ratings for INBP and its competitors with MarketBeat's FREE daily newsletter.

Integrated BioPharma (OTCMKTS:INBP) Frequently Asked Questions

What is Integrated BioPharma's stock symbol?

Integrated BioPharma trades on the OTCMKTS under the ticker symbol "INBP."

When is Integrated BioPharma's next earnings date?

Integrated BioPharma is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Integrated BioPharma.

Has Integrated BioPharma been receiving favorable news coverage?

News stories about INBP stock have been trending extremely negative this week, according to InfoTrie. The research firm scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Integrated BioPharma earned a coverage optimism score of -5.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Integrated BioPharma.

Who are Integrated BioPharma's key executives?

Integrated BioPharma's management team includes the folowing people:
  • Mr. E. Gerald Kay, Exec. Chairman (Age 83)
  • Ms. Riva Kay Sheppard, Co-CEO & Director (Age 52)
  • Ms. Christina Kay, Co-CEO & Director (Age 49)
  • Ms. Dina L. Masi, Sr. VP, CFO & Sec. (Age 58)
  • Mr. Jamie E. Levey, Head of Investor Relations

How do I buy shares of Integrated BioPharma?

Shares of INBP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Integrated BioPharma's stock price today?

One share of INBP stock can currently be purchased for approximately $0.36.

MarketBeat Community Rating for Integrated BioPharma (OTCMKTS INBP)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  40 (Vote Underperform)
Total Votes:  102
MarketBeat's community ratings are surveys of what our community members think about Integrated BioPharma and other stocks. Vote "Outperform" if you believe INBP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INBP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: Portfolio Manager

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel